Recent developments in biologic therapies may bring an end to the off-label use of chemotherapy and other salvage therapies in hemophagocytic lymphohistiocytosis. Image Source: Wikimedia Commons user: Bill Branson Cancer may be the darling of the research world, but there are other, rarer diseases that require just as much care […]
Research management technologies enable researchers to organize and leverage critical data in order to decide whether to transport crude oil from a particular well by pipeline, truck, rail or boat.
By looking at the “seed and soil” hypothesis, it may be possible to draw blood and predict whether cancer is about to go metastatic and where mets will grow based on a variety of different biomarkers.
By paying attention to consumers who are concerned about the health risks of current toothpaste ingredients, CPG companies can gain a foothold in the growing market for triclosan- and fluoride-free oral health solutions.
As life science firms look for patient populations to help by designing novel biotherapeutics, they will need to ensure their research efforts allow for efficient drug discovery and development.
Despite the rising demand for pesticides worldwide, companies are facing increased pressure from regulatory agencies to demonstrate the environmental and health safety of these products. To meet market demand, firms will need to adopt solutions that enable continual advances in crop protection products while also keeping costs down.
In order to take full advantage of the power of machine learning, researchers at oil and gas companies need to be able to work with many large datasets from multiple research departments, and it can be tough to keep it all in order using traditional paper notebooks.
Frequent fluctuations in the regulatory environment can pose challenges for oil and gas researchers who are seeking to to improve the materials and methods used in hydraulic fracturing. Electronic lab notebooks make it easy to access previous data, and, if necessary, use it to update or alter their recommendations based on new regulations.
In August 2016, NIH released a proposal to reinstate funding for human-animal chimera research—subject to certain stipulations. With a quality strategy in place, labs can ensure that they are in compliance as they conduct cutting-edge disease research using human-animal chimeras.
Restructuring and streamlining operations have been a core strategy for many pharmaceutical companies in recent years. But while small molecule and solid dosage efforts are often the target of such cost-cutting measures, life sciences firms have been concentrating on increasing biologics manufacturing efforts.